Bayesian Assessment of the Influence and Interaction Conditions in Multipopulation Tailoring Clinical Trials

REFERENCES

• Alosh , M. , Hugue , M. F. ( 2013 ). Multiplicity considerations for subgroup analysis subject to consistency constraint . Biometrical Journal 55 : 444 – 462 .
   PubMed Web of Science ®Google Scholar
• Berry , S. M. , Carlin , B. P. , Lee , J. J. , Muller , P. ( 2010 ). Bayesian Adaptive Methods for Clinical Trials . New York , NY : CRC Press .
   Google Scholar
• Food and Drug Administration . ( 2012 ). Guidance for industry: Enrichment strategies for clinical trials to support approval of human drugs and biological products. Available at: www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ ucm332181.pdf
   Google Scholar
• Freidlin , B. , McShane , L. M. , Korn , E. L. ( 2010 ). Randomized clinical trials with biomarkers: Design issues . Journal of the National Cancer Institute 102 : 152 – 160 .
   PubMed Web of Science ®Google Scholar
• Freidlin , B. , McShane , L. M. , Polley , M. C. , Korn , E. L. ( 2012 ). Randomized Phase II trial designs with biomarkers . Journal of Clinical Oncology 30 : 3304 – 3309 .
   PubMed Web of Science ®Google Scholar
• Herson , J. ( 1979 ). Predictive probability early termination plans for Phase II clinical trials . Biometrics 35 : 775 – 783 .
   PubMed Web of Science ®Google Scholar
• Jia , G. , Erickson , R. W. , Choy , D. F. , Mosesova , S. , Wu , L. C. , Solberg , O. D. , Shikotra , A. , Carter , R. , Audusseau , S. , Hamid , Q. , Bradding , P. , Fahy , J. V. , Woodruff , P. G. , Harris , J. M. , Arron , J. R. (2012). Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. Journal of Allergy and Clinical Immunology 130:647–654.
   PubMed Web of Science ®Google Scholar
• Millen , B. A. , Dmitrienko , A. , Ruberg , S. , Shen , L. ( 2012 ). A statistical framework for decision making in confirmatory multipopulation tailoring clinical trials . Drug Information Journal 46 : 647 – 656 .
   Web of Science ®Google Scholar
• Millen , B. A. , Dmitrienko , A. , Mandrekar , S. J. , Zhang , Z. , Williams , D. ( 2014 ). Multipopulation tailoring clinical trials: Design, analysis, and inference considerations. Therapeutic Innovation and Regulatory Science. In press .
   Google Scholar
• Pennello , G. , Thompson , L. ( 2008 ). Experience with reviewing Bayesian medical device trials . Journal of Biopharmaceutical Statistics 18 : 81 – 115 .
   PubMed Web of Science ®Google Scholar
• Rothmann , M. D. , Zhang , J. J. , Lu , L. , Fleming , T. R. ( 2012 ). Testing in a pre-specified subgroup and the intent-to-treat population . Drug Information Journal 46 : 175 – 179 .
   PubMed Web of Science ®Google Scholar
• Sequist , L. V. , von Pawel , J. , Garmey , E. G. ( 2011 ). Randomized phase II study of erlotinib plus tivantinib versus erlotinib plus placebo in previously treated non-small-cell lung cancer . Journal of Clinical Oncology 29 : 3307 – 3315 .
   PubMed Web of Science ®Google Scholar
• Simon , R. , Wang , S. J. ( 2006 ). Use of genomic signatures in therapeutics development in oncology and other diseases . Pharmacogenomics Journal 6 : 166 – 173 .
   PubMed Web of Science ®Google Scholar
• Spiegelhalter , D. J. , Abrams , K. R. , Myles , J. P. ( 2004 ). Bayesian Approaches to Clinical Trials and Health-Care Evaluation . Chichester : Wiley .
   Google Scholar
• Wang , S. J. , O'Neill , R. T. , Hung , H. M. J. ( 2007 ). Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset . Pharmaceutical Statistics 6 : 227 – 244 .
   PubMed Web of Science ®Google Scholar
• Color versions of one or more of the figures in the article can be found online at www.tandfonline.com/lbps.
   Google Scholar